{"organizations": [], "uuid": "52ba14d52d237ad13f8b7d36dda2b0ad97fc3be3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/07/the-associated-press-protagonist-therapeutics-posts-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Protagonist Therapeutics posts 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-07T23:58:00.000+02:00", "replies_count": 0, "uuid": "52ba14d52d237ad13f8b7d36dda2b0ad97fc3be3"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/07/the-associated-press-protagonist-therapeutics-posts-4q-loss.html", "ord_in_thread": 0, "title": "Protagonist Therapeutics posts 4Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "newark", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "newark", "sentiment": "none"}], "organizations": [{"name": "ptgx", "sentiment": "negative"}, {"name": "protagonist therapeutics inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $3.1 million in its fourth quarter.\nOn a per-share basis, the Newark, California-based company said it had a loss of 15 cents.\nThe biopharmaceutical company posted revenue of $11.3 million in the period.\nFor the year, the company reported that its loss narrowed to $37 million, or $2.09 per share. Revenue was reported as $20.1 million.\nProtagonist Therapeutics shares have increased slightly since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $20.89, a climb of 55 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX", "external_links": [], "published": "2018-03-07T23:58:00.000+02:00", "crawled": "2018-03-08T00:11:24.001+02:00", "highlightTitle": ""}